Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Daniel Kelly

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
American Journal of Epidemiology|April 29, 2023
SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic RecencySaki Takahashi, Michael J Peluso, Jill Hakim, et al.
The Lancet. Infectious Diseases|May 19, 2022
Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease in Liberia: a longitudinal cohort studyJ Daniel Kelly, Collin Van Ryn, Moses Badio, et al.
PLOS Global Public Health|April 16, 2025
Post-Omicron SARS-CoV-2 antibody prevalence in Sierra Leone: A cross-sectional, nationally representative, follow-up serosurveySmit Chitre, Mohamed Bailor Barrie, Joseph Sam Kanu, et al.
Annals of Clinical and Translational Neurology|January 19, 2022
Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19Alexandra C Apple, Alexis Oddi, Michael J Peluso, et al.
Journal of Neurovirology|February 2, 2021
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patientsJoanna Hellmuth, T Allen Barnett, Breton M Asken, et al.
The Journal of Infectious Diseases|September 12, 2022
Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVIDMichael J Peluso, Anthea Mitchell, Chung Yu Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative studyEdda I Santiago-Rodriguez, Andres Maiorana, Michael J Peluso, et al.
International Journal of Behavioral Medicine|December 17, 2021
Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and RecoveryEdda I Santiago-Rodriguez, Andres Maiorana, Michael J Peluso, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Epstein Barr viral shedding dynamics in saliva during acute SARS-CoV-2 infectionMiguel A Garcia-Knight, Jessica Y Chen, Amethyst Zhang, et al.
Vaccine|November 20, 2021
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of CongoNicole A Hoff, Anna Bratcher, Patrick Mukadi, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
American Journal of Epidemiology|April 29, 2023
SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic RecencySaki Takahashi, Michael J Peluso, Jill Hakim, et al.
The Lancet. Infectious Diseases|May 19, 2022
Clinical sequelae among individuals with pauci-symptomatic or asymptomatic Ebola virus infection and unrecognised Ebola virus disease in Liberia: a longitudinal cohort studyJ Daniel Kelly, Collin Van Ryn, Moses Badio, et al.
PLOS Global Public Health|April 16, 2025
Post-Omicron SARS-CoV-2 antibody prevalence in Sierra Leone: A cross-sectional, nationally representative, follow-up serosurveySmit Chitre, Mohamed Bailor Barrie, Joseph Sam Kanu, et al.
Annals of Clinical and Translational Neurology|January 19, 2022
Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19Alexandra C Apple, Alexis Oddi, Michael J Peluso, et al.
Journal of Neurovirology|February 2, 2021
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patientsJoanna Hellmuth, T Allen Barnett, Breton M Asken, et al.
The Journal of Infectious Diseases|September 12, 2022
Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVIDMichael J Peluso, Anthea Mitchell, Chung Yu Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative studyEdda I Santiago-Rodriguez, Andres Maiorana, Michael J Peluso, et al.
International Journal of Behavioral Medicine|December 17, 2021
Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and RecoveryEdda I Santiago-Rodriguez, Andres Maiorana, Michael J Peluso, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Epstein Barr viral shedding dynamics in saliva during acute SARS-CoV-2 infectionMiguel A Garcia-Knight, Jessica Y Chen, Amethyst Zhang, et al.
Vaccine|November 20, 2021
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of CongoNicole A Hoff, Anna Bratcher, Patrick Mukadi, et al.
Pageof 14